Evidence map›Paper›PMID 40286246›Full record

ArticleMolecules (Basel, Switzerland)2025

Investigation of Anticancer Peptides Derived from

Jixu Wu, Xiuhua Zhang, Yuting Jin, Man Zhang, Rongmin Yu, Liyan Song, Fei Liu, Jianhua Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jixu WuBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.
Xiuhua ZhangShandong Engineering Research Center for Efficient Preparation and Application of Sugar and Sugar Complex, Shandong Academy of Pharmaceutical Science, Jinan 250101, China.
Yuting JinBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.
Man ZhangBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.
Rongmin YuBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.
Liyan SongBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.
Fei LiuShandong Engineering Research Center for Efficient Preparation and Application of Sugar and Sugar Complex, Shandong Academy of Pharmaceutical Science, Jinan 250101, China.
Jianhua ZhuBiotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.

Funding

Guangzhou Science and Technology Plan Project 2023A03J0613Key R&D Program of Shandong Province 2022SFGC0105Natural Science Foundation of Guangdong province 2024A1515010301Special Fund for Talent Development of Jinan 2021GXRC072
6 · The paper itself

Abstract

This study employed an integrated in silico approach to identify and characterize anticancer peptides (ACPs) derived from

Indexed as

Antineoplastic AgentsPeptidesAmino Acid SequenceCell Line, TumorComputational BiologyComputer SimulationHumansAntineoplastic AgentsPeptidesanticancerbioactive peptidesin silico analysisproteins from Arca species

Identifiers

PMID40286246
PMCPMC11990805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.